Modified USA Dressing Forceps 21cm — Lung Cancer Surgery

Modified USA Dressing Forceps — 21cm Lung Cancer Surgery

The 21cm-labelled Modified USA dressing forceps serves lung-cancer surgery — pulmonary lobectomy, segmentectomy, and sleeve resection for non-small-cell lung cancer (NSCLC). American lung-cancer surgery has shifted significantly toward VATS and robotic approaches in the past 15 years; the 21cm Modified USA serves the open-conversion tray and the residual open-procedure cases.

The lobectomy versus segmentectomy debate

Pulmonary lobectomy with hilar lymphadenectomy was the standard lung-cancer-surgery approach for decades, based on the 1995 LCSG trial showing higher recurrence with sublobar resection. The 2023 JCOG0802 and CALGB140503 trials demonstrated non-inferior outcomes for segmentectomy in small (<2cm) peripheral NSCLC, leading to renewed adoption of parenchymal-preservation surgery. The 21cm Modified USA forceps serves both procedures.

The minimally-invasive thoracic evolution

VATS lobectomy and robotic lobectomy now represent the majority of American lung-cancer surgical practice. The open thoracotomy remains for selected cases (large tumours, chest-wall involvement, conversion from minimally-invasive approach). The 21cm Modified USA continues to populate the conversion-tray inventory.